You are here »
Home »
Company » Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Ltd.
BSE: 532296 |
Sector: Health care |
NSE: GLENMARK |
ISIN Code: INE935A01035 |
BSE
00:00 | 01 Jul
|
394.00
|
7.00 (1.81%)
|
OPEN
390.50
|
HIGH
394.50
|
LOW
382.05
|
NSE
00:00 | 01 Jul
|
394.10
|
7.75 (2.01%)
|
OPEN
385.20
|
HIGH
395.00
|
LOW
382.00
|
OPEN |
390.50 |
PREVIOUS CLOSE |
387.00 |
VOLUME |
29078 |
52-Week high |
690.60 |
52-Week low |
348.90 |
P/E |
6.77 |
Mkt Cap.(Rs cr) |
11,119 |
Buy Price |
0.00 |
Buy Qty |
0.00 |
Sell Price |
0.00 |
Sell Qty |
0.00 |
OPEN |
385.20 |
PREVIOUS CLOSE |
386.35 |
VOLUME |
398227 |
52-Week high |
690.95 |
52-Week low |
348.50 |
P/E |
6.77 |
Mkt Cap.(Rs cr) |
11,119 |
Buy Price |
394.10 |
Buy Qty |
551.00 |
Sell Price |
0.00 |
Sell Qty |
0.00 |
OPEN |
390.50 |
CLOSE |
387.00 |
VOLUME |
29078 |
52-Week high |
690.60 |
52-Week low |
348.90 |
P/E |
6.77 |
Mkt Cap.(Rs cr) |
11,119 |
Buy Price |
0.00 |
Buy Qty |
0.00 |
Sell Price |
0.00 |
Sell Qty |
0.00 |
OPEN |
385.20 |
PREVIOUS CLOSE |
386.35 |
VOLUME |
398227 |
52-Week high |
690.95 |
52-Week low |
348.50 |
P/E |
6.77 |
Mkt Cap.(Rs cr) |
11118.68 |
Buy Price |
394.10 |
Buy Qty |
551.00 |
Sell Price |
0.00 |
Sell Qty |
0.00 |
About Glenmark Pharmaceuticals Ltd.
Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Ltd was incorporated in November 18th 1977. The company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). It is engaged in the business of development manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets. The...> More
Glenmark Pharmaceuticals Ltd - Key Fundamentals
Glenmark Pharmaceuticals Ltd - Financial Results
Particulars ( cr) |
Mar 2022 |
Mar 2021 |
% Chg |
Net Sales |
3019.15 |
2859.9 |
5.57 |
Other Income |
107.2 |
8.49 |
1162.66 |
Total Income |
3126.35 |
2868.39 |
8.99 |
Total Expenses |
2638.28 |
2336.47 |
12.92 |
Operating Profit |
488.07 |
531.92 |
-8.24 |
Net Profit |
172.57 |
233.87 |
-26.21 |
Equity Capital |
28.22 |
28.22 |
- |
> More on Glenmark Pharmaceuticals Ltd Financials Results
Glenmark Pharmaceuticals Ltd - Peer Group
Glenmark Pharmaceuticals Ltd - SHAREHOLDING PATTERN
Glenmark Pharmaceuticals Ltd - Research Reports
Glenmark Pharmaceuticals Ltd - RETURNS
Period |
BSE |
NSE |
Sensex |
NIFTY |
1 Week |
2.67% |
2.59% |
0.34% |
0.34% |
1 Month |
1.30% |
1.34% |
-4.47% |
-4.66% |
3 Month |
-12.88% |
-12.88% |
-10.74% |
-10.86% |
6 Month |
-25.42% |
-25.44% |
-9.18% |
-9.23% |
1 Year |
-39.66% |
-39.66% |
1.13% |
0.46% |
3 Year |
-10.71% |
-10.69% |
33.31% |
32.75% |
Glenmark Pharmaceuticals Ltd - STOCK STRENGTH
Today's Low/High |
382.05 |
|
394.50 |
Week Low/High |
374.80 |
|
396.00 |
Month Low/High |
348.90 |
|
402.00 |
YEAR Low/High |
348.90 |
|
691.00 |
All TIME Low/High |
1.89 |
|
1262.00 |
Quick Links for Glenmark Pharmaceuticals: